NEW YORK – The US Food and Drug Administration on Monday issued an alert to patients and healthcare providers warning them of a risk of false negative results with a SARS-CoV-2 laboratory-based test from San Dimas, California-based Curative.
The agency asserted that the test, to which it granted Emergency Use Authorization in April, must be performed in accordance with its labeling to ensure correct results.